MedPath

Pharmacological, Clinical and Statistical Assessment of a New Tool Available for Pharmacodependence Report Evaluation

Completed
Conditions
Drug Abuse
Drug Dependence
Registration Number
NCT01052675
Lead Sponsor
Nantes University Hospital
Brief Summary

In France, the Afssaps is the body in charge of the evaluation of pharmacodependance. In order to fulfil its mission, the Afssaps has created a network of 11 Centres for Evaluation and Information on Pharmacodependance (CEIP), coordinated by the Drugs and Psychotropics Unit. Pharmacodependence notifications issued by professionals are collected by each Centre which evaluates them. Nantes' CEIP created an original tool to harmonize case reporting and make it possible to homogeneously evaluate the seriousness of pharmacodependence cases as each CEIP had his own way of analysing his cases. The aim of this study is to assess this tool.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
3180
Inclusion Criteria
  • case report from one of the French CEIP for drug and substance problematic use, abuse or dependence except alcohol and tobacco.
Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Psychometrics properties Evaluation of the new questionnaire centered on addiction to medicine .At the beginning of the study
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (10)

Hôpital Pellegrin

🇫🇷

Bordeaux, France

CHRU de Caen

🇫🇷

Caen, France

CHU de Grenoble

🇫🇷

Grenoble, France

Centre Antipoison - Centre de Pharmacovigilance

🇫🇷

Lyon, France

Hôpital Salvator

🇫🇷

Marseille, France

Hôpital Lapeyronie

🇫🇷

Montpellier, France

CHU de Nancy

🇫🇷

Nancy, France

CHU de Nantes

🇫🇷

Nantes, France

Hôpital Fernand Widal

🇫🇷

Paris, France

Faculté de médecine

🇫🇷

Toulouse, France

Hôpital Pellegrin
🇫🇷Bordeaux, France

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.